Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis
Catherine Emmanuel(Peter MacCallum Cancer Centre), Anna DeFazio(The University of Sydney), Natalie Gava(The University of Sydney), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Joshy George(Jackson Laboratory), Gerard Wain(Westmead Hospital), Catherine J. Kennedy(The University of Sydney), Christine L. Clarke(Memorial University of Newfoundland), Paul R. Harnett(The University of Sydney), Alison H. Brand(The University of Sydney), Rosemary L. Balleine(The University of Sydney), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Raghwa Sharma(Royal Prince Alfred Hospital), Michael J. Birrer(University of Arkansas Medical Center), Russell Hogg(Westmead Hospital), David D.L. Bowtell(The University of Melbourne)
Cited by 40
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k